Skip to main content
Journal cover image

OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406.

Publication ,  Journal Article
Janne, PA; Wang, X; Socinski, MA; Crawford, J; Gu, L; Capelletti, M; Edelman, MJ; Villalona-Calero, MA; Kratzke, RA; Vokes, E; Miller, VA
Published in: JOURNAL OF THORACIC ONCOLOGY
June 1, 2011

Duke Scholars

Published In

JOURNAL OF THORACIC ONCOLOGY

EISSN

1556-1380

ISSN

1556-0864

Publication Date

June 1, 2011

Volume

6

Issue

6

Start / End Page

S447 / S448

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Janne, P. A., Wang, X., Socinski, M. A., Crawford, J., Gu, L., Capelletti, M., … Miller, V. A. (2011). OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406. JOURNAL OF THORACIC ONCOLOGY, 6(6), S447–S448.
Janne, Pasi A., Xiaofei Wang, Mark A. Socinski, Jeffrey Crawford, Lin Gu, Marzia Capelletti, Martin J. Edelman, et al. “OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406.JOURNAL OF THORACIC ONCOLOGY 6, no. 6 (June 1, 2011): S447–48.
Janne PA, Wang X, Socinski MA, Crawford J, Gu L, Capelletti M, et al. OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406. JOURNAL OF THORACIC ONCOLOGY. 2011 Jun 1;6(6):S447–8.
Janne, Pasi A., et al. “OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406.JOURNAL OF THORACIC ONCOLOGY, vol. 6, no. 6, LIPPINCOTT WILLIAMS & WILKINS, June 2011, pp. S447–48.
Janne PA, Wang X, Socinski MA, Crawford J, Gu L, Capelletti M, Edelman MJ, Villalona-Calero MA, Kratzke RA, Vokes E, Miller VA. OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406. JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2011 Jun 1;6(6):S447–S448.
Journal cover image

Published In

JOURNAL OF THORACIC ONCOLOGY

EISSN

1556-1380

ISSN

1556-0864

Publication Date

June 1, 2011

Volume

6

Issue

6

Start / End Page

S447 / S448

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology